Scholars Central

Review articlePublished 2015

Influences of Gut Hormones on Hepatocellular Carcinoma

Authors: Wei-Ju Huang

Endocrinology & Metabolic Syndrome

Volume 4 · Issue 1 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hepatocellular Carcinoma (HCC) is worldwide the fifth most common cancer in men and represents the third most frequent cause of cancer death. Development of new therapeutic agents is of paramount importance in the management of HCC patients. Known studies indicated that most gut hormones were the promoter in HCC, including ghrelin, Cholecystokinin (CCK), gastrin, secretion, growth factor and leptin. Although these hormones have the different functions in digestion, most of them increase or have active expression in HCC. Presently, Gastrointestinal (GI) imaging is not good tips and traps in the diagnosis of small HCC. How to use the analysis of gut hormones to examine the liver function or detect the HCC is important. We hope that these findings can serve a good knowledge to therapy HCC

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Endocrinology & Metabolic Syndrome.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEndocrinology & Metabolic Syndrome
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Wei-Ju Huang”